Skip to main content
Top
Published in: Japanese Journal of Ophthalmology 1/2022

01-01-2022 | Macular Degeneration | Clinical Investigation

Dry age-related macular degeneration in the Japanese population

Authors: Akitaka Tsujikawa, Kanji Takahashi, Ryo Obata, Tomohiro Iida, Yasuo Yanagi, Hideki Koizumi, Hidetoshi Yamashita, Fumio Shiraga, Taiji Sakamoto

Published in: Japanese Journal of Ophthalmology | Issue 1/2022

Login to get access

Abstract

Purpose

To elucidate the clinical characteristics of eyes with dry age-related macular degeneration (AMD) in Japan.

Study design

Retrospective.

Methods

We performed a nationwide survey of dry AMD. A questionnaire on dry AMD was sent to 3,801 major hospitals and eye clinics nationwide. Whenever both eyes met the diagnostic criteria, only the eye with more advanced geographic atrophy was included.

Results

In the current survey, 81 patients (81 eyes) with dry AMD were included. Of the 81 patients, 56 (69.1%) were men, and the mean age of the patients was 76.6 ± 8.4 (range, 54–94) years. Twenty-four patients (29.6%) had a history of smoking. The decimal best corrected-visual acuity (BCVA) was equal to or better than 0.7 in 25 eyes (30.9%), but worse than 0.1 in 17 eyes (21.0%). The mean BCVA was 0.62 ± 0.59 in logarithm of the minimum angle of resolution. Lesion size (the greatest linear dimension of the largest geographic atrophy) was ≥ 2 disc diameter in 33 eyes (40.7%) and < 1 disc diameter in 21 eyes (25.9%). Soft drusen was observed in 27 eyes (33.3%), and reticular pseudodrusen was observed in 31 eyes (38.3%). Of the 81 patients, the other eye was diagnosed as dry AMD in 26 eyes (32.1%), neovascular AMD in 16 eyes (19.8%), and intermediate AMD in 18 eyes (22.2%).

Conclusion

Dry AMD in the Japanese population has characteristics of male predominance, older age, high prevalence of reticular pseudodrusen, and high bilaterality.
Literature
1.
go back to reference Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.CrossRef Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.CrossRef
2.
go back to reference Guymer R, Wu Z. Age-related macular degeneration (AMD): more than meets the eye. The role of multimodal imaging in today’s management of AMD-A review. Clin Exp Ophthalmol. 2020;48:983–95.CrossRef Guymer R, Wu Z. Age-related macular degeneration (AMD): more than meets the eye. The role of multimodal imaging in today’s management of AMD-A review. Clin Exp Ophthalmol. 2020;48:983–95.CrossRef
3.
go back to reference Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, et al. Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol. 2019;63:374–81.CrossRef Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, et al. Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol. 2019;63:374–81.CrossRef
4.
go back to reference Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren CM. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121:1079–91.CrossRef Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren CM. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121:1079–91.CrossRef
5.
go back to reference Shen LL, Sun M, Grossetta Nardini HK, Del Priore LV. Progression of unifocal versus multifocal geographic atrophy in age-related macular degeneration: a systematic review and meta-analysis. Ophthalmol Retina. 2020;4:899–910.CrossRef Shen LL, Sun M, Grossetta Nardini HK, Del Priore LV. Progression of unifocal versus multifocal geographic atrophy in age-related macular degeneration: a systematic review and meta-analysis. Ophthalmol Retina. 2020;4:899–910.CrossRef
6.
go back to reference Michels S, Schmidt-Erfurth U, Rosenfeld PJ. Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs. 2006;15:779–93.CrossRef Michels S, Schmidt-Erfurth U, Rosenfeld PJ. Promising new treatments for neovascular age-related macular degeneration. Expert Opin Investig Drugs. 2006;15:779–93.CrossRef
7.
go back to reference New CC. New anti-vegf drugs in ophthalmology. Curr Drug Targets. 2020;21:1194–200.CrossRef New CC. New anti-vegf drugs in ophthalmology. Curr Drug Targets. 2020;21:1194–200.CrossRef
8.
go back to reference Cheng QE, Gao J, Kim BJ, Ying GS. Design characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrials.gov. Ophthalmol Retina. 2018;2:518–25.CrossRef Cheng QE, Gao J, Kim BJ, Ying GS. Design characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrials.gov. Ophthalmol Retina. 2018;2:518–25.CrossRef
9.
go back to reference Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72.CrossRef Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72.CrossRef
10.
go back to reference Wilde C, Poostchi A, Hillman JG, MacNab HK, Vernon SA, Amoaku WM. Characteristics of geographic atrophy in an elderly UK population-The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002–2006). Eye (Lond). 2021;35:1697–704.CrossRef Wilde C, Poostchi A, Hillman JG, MacNab HK, Vernon SA, Amoaku WM. Characteristics of geographic atrophy in an elderly UK population-The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002–2006). Eye (Lond). 2021;35:1697–704.CrossRef
11.
go back to reference Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010;117:921–7.CrossRef Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010;117:921–7.CrossRef
12.
go back to reference Koizumi H, Yamamoto A, Ogasawara M, Maruko I, Hasegawa T, Itagaki K, et al. Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study. Jpn J Ophthalmol. 2020;64:338–45.CrossRef Koizumi H, Yamamoto A, Ogasawara M, Maruko I, Hasegawa T, Itagaki K, et al. Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study. Jpn J Ophthalmol. 2020;64:338–45.CrossRef
13.
go back to reference Matsumoto H, Mukai R, Kikuchi Y, Morimoto M, Akiyama H. One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions. Jpn J Ophthalmol. 2020;64:203–9.CrossRef Matsumoto H, Mukai R, Kikuchi Y, Morimoto M, Akiyama H. One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions. Jpn J Ophthalmol. 2020;64:203–9.CrossRef
14.
go back to reference Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127:533–40.CrossRef Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127:533–40.CrossRef
15.
go back to reference Takahashi A, Ooto S, Yamashiro K, Tamura H, Oishi A, Miyata M, et al. Pachychoroid geographic atrophy: clinical and genetic characteristics. Ophthalmol Retina. 2018;2:295–305.CrossRef Takahashi A, Ooto S, Yamashiro K, Tamura H, Oishi A, Miyata M, et al. Pachychoroid geographic atrophy: clinical and genetic characteristics. Ophthalmol Retina. 2018;2:295–305.CrossRef
16.
go back to reference Sakurada Y, Yoneyama S, Sugiyama A, Tanabe N, Kikushima W, Mabuchi F, et al. Prevalence and genetic characteristics of geographic atrophy among elderly Japanese with age-related macular degeneration. PLoS ONE. 2016;11:e0149978.CrossRef Sakurada Y, Yoneyama S, Sugiyama A, Tanabe N, Kikushima W, Mabuchi F, et al. Prevalence and genetic characteristics of geographic atrophy among elderly Japanese with age-related macular degeneration. PLoS ONE. 2016;11:e0149978.CrossRef
17.
go back to reference Takahashi K, Shiraga F, Ishida S, Kamei M, Yanagi Y, Yoshimura N. Diagnostic criteria for atrophic age-related macular degeneration. Nippon Ganka Gakkai Zasshi. 2015;119:671–7 ((in Japanese)).PubMed Takahashi K, Shiraga F, Ishida S, Kamei M, Yanagi Y, Yoshimura N. Diagnostic criteria for atrophic age-related macular degeneration. Nippon Ganka Gakkai Zasshi. 2015;119:671–7 ((in Japanese)).PubMed
18.
go back to reference Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96:752–6.CrossRef Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96:752–6.CrossRef
19.
go back to reference Bikbov MM, Zainullin RM, Gilmanshin TR, Kazakbaeva GM, Rakhimova EM, Rusakova IA, et al. Prevalence and associated factors of age-related macular degeneration in a Russian population: The Ural Eye and Medical Study. Am J Ophthalmol. 2020;210:146–57.CrossRef Bikbov MM, Zainullin RM, Gilmanshin TR, Kazakbaeva GM, Rakhimova EM, Rusakova IA, et al. Prevalence and associated factors of age-related macular degeneration in a Russian population: The Ural Eye and Medical Study. Am J Ophthalmol. 2020;210:146–57.CrossRef
20.
go back to reference Rim TH, Kawasaki R, Tham YC, Kang SW, Ruamviboonsuk P, Bikbov MM, et al. Prevalence and pattern of geographic atrophy in Asia: the Asian Eye Epidemiology Consortium. Ophthalmology. 2020;127:1371–81.CrossRef Rim TH, Kawasaki R, Tham YC, Kang SW, Ruamviboonsuk P, Bikbov MM, et al. Prevalence and pattern of geographic atrophy in Asia: the Asian Eye Epidemiology Consortium. Ophthalmology. 2020;127:1371–81.CrossRef
21.
go back to reference Obata R, Yanagi Y, Inoue T, Yasuda M, Oshima Y, Sawaguchi S, et al. Prevalence and factors associated with age-related macular degeneration in a southwestern island population of Japan: the Kumejima Study. Br J Ophthalmol. 2018;102:1047–53.CrossRef Obata R, Yanagi Y, Inoue T, Yasuda M, Oshima Y, Sawaguchi S, et al. Prevalence and factors associated with age-related macular degeneration in a southwestern island population of Japan: the Kumejima Study. Br J Ophthalmol. 2018;102:1047–53.CrossRef
22.
go back to reference Nakata I, Yamashiro K, Nakanishi H, Akagi-Kurashige Y, Miyake M, Tsujikawa A, et al. Prevalence and characteristics of age-related macular degeneration in the Japanese population: the Nagahama study. Am J Ophthalmol. 2013;156:1002–9.CrossRef Nakata I, Yamashiro K, Nakanishi H, Akagi-Kurashige Y, Miyake M, Tsujikawa A, et al. Prevalence and characteristics of age-related macular degeneration in the Japanese population: the Nagahama study. Am J Ophthalmol. 2013;156:1002–9.CrossRef
23.
go back to reference Sasaki M, Harada S, Kawasaki Y, Watanabe M, Ito H, Tanaka H, et al. Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population. Sci Rep. 2018;8:785.CrossRef Sasaki M, Harada S, Kawasaki Y, Watanabe M, Ito H, Tanaka H, et al. Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population. Sci Rep. 2018;8:785.CrossRef
24.
go back to reference Fujiwara K, Yasuda M, Hata J, Oshima Y, Hashimoto S, Yoshitomi T, et al. Prevalence and risk factors for polypoidal choroidal vasculopathy in a general Japanese population: the Hisayama Study. Semin Ophthalmol. 2018;33:813–9.CrossRef Fujiwara K, Yasuda M, Hata J, Oshima Y, Hashimoto S, Yoshitomi T, et al. Prevalence and risk factors for polypoidal choroidal vasculopathy in a general Japanese population: the Hisayama Study. Semin Ophthalmol. 2018;33:813–9.CrossRef
25.
go back to reference Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology. 2008;115:1376–81.CrossRef Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology. 2008;115:1376–81.CrossRef
26.
go back to reference Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119:571–80.CrossRef Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119:571–80.CrossRef
27.
go back to reference Yamashiro K, Hosoda Y, Miyake M, Ooto S, Tsujikawa A. Characteristics of pachychoroid diseases and age-related macular degeneration: multimodal imaging and genetic backgrounds. J Clin Med. 2020;9:2034.CrossRef Yamashiro K, Hosoda Y, Miyake M, Ooto S, Tsujikawa A. Characteristics of pachychoroid diseases and age-related macular degeneration: multimodal imaging and genetic backgrounds. J Clin Med. 2020;9:2034.CrossRef
28.
go back to reference Yamashiro K, Hosoda Y, Miyake M, Takahashi A, Ooto S, Tsujikawa A. Hypothetical pathogenesis of age-related macular degeneration and pachychoroid diseases derived from their genetic characteristics. Jpn J Ophthalmol. 2020;64:555–67.CrossRef Yamashiro K, Hosoda Y, Miyake M, Takahashi A, Ooto S, Tsujikawa A. Hypothetical pathogenesis of age-related macular degeneration and pachychoroid diseases derived from their genetic characteristics. Jpn J Ophthalmol. 2020;64:555–67.CrossRef
29.
go back to reference Yanagi Y. Pachychoroid disease: a new perspective on exudative maculopathy. Jpn J Ophthalmol. 2020;64:323–37.CrossRef Yanagi Y. Pachychoroid disease: a new perspective on exudative maculopathy. Jpn J Ophthalmol. 2020;64:323–37.CrossRef
30.
go back to reference Komuku Y, Iwahashi C, Gomi F. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2020;64:265–70.CrossRef Komuku Y, Iwahashi C, Gomi F. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2020;64:265–70.CrossRef
31.
go back to reference Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204.CrossRef Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204.CrossRef
32.
go back to reference Biarnes M, Colijn JM, Sousa J, Ferraro LL, Garcia M, Verzijden T, et al. Genotype- and phenotype-based subgroups in geographic atrophy secondary to age-related macular degeneration: the EYE-RISK Consortium. Ophthalmol Retina. 2020;4:1129–37.CrossRef Biarnes M, Colijn JM, Sousa J, Ferraro LL, Garcia M, Verzijden T, et al. Genotype- and phenotype-based subgroups in geographic atrophy secondary to age-related macular degeneration: the EYE-RISK Consortium. Ophthalmol Retina. 2020;4:1129–37.CrossRef
Metadata
Title
Dry age-related macular degeneration in the Japanese population
Authors
Akitaka Tsujikawa
Kanji Takahashi
Ryo Obata
Tomohiro Iida
Yasuo Yanagi
Hideki Koizumi
Hidetoshi Yamashita
Fumio Shiraga
Taiji Sakamoto
Publication date
01-01-2022
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 1/2022
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-021-00892-y

Other articles of this Issue 1/2022

Japanese Journal of Ophthalmology 1/2022 Go to the issue